Chevallard Daniel R.
Chief Financial Officer
Chevallard Daniel R. has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Mar 30, 2026.
On the most recent filing, Chevallard Daniel R. is listed as Chief Financial Officer at LENZ Therapeutics, Inc. Inside the rolling window, Chevallard Daniel R. reported 2 open-market purchases totaling $114K in LENZ and no open-market sales. The largest disclosed transaction in the window is a purchase of 7,500 LENZ shares on Mar 27, 2026, worth $64K.
Companies traded
Other insiders at LENZ
Insider Buying
$114K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Chevallard Daniel R. made?
Chevallard Daniel R. has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Chevallard Daniel R. trade?
Chevallard Daniel R. has filed SEC Form 4 disclosures for 1 company, including LENZ.
When was Chevallard Daniel R.'s most recent SEC Form 4 filing?
Chevallard Daniel R.'s most recent SEC Form 4 filing on Tracefour is dated Mar 30, 2026.
What is Chevallard Daniel R.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Chevallard Daniel R. is listed as Chief Financial Officer.
What is Chevallard Daniel R.'s total buy and sell value in the current window?
Inside the rolling retention window, Chevallard Daniel R. bought $114K and sold $0 based on SEC Form 4 filings.
What was Chevallard Daniel R.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 7,500 LENZ shares on 2026-03-27, worth $64K, per SEC Form 4 filings.